Correlation Between Bio Gene and Imugene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bio Gene and Imugene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Gene and Imugene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Gene Technology and Imugene, you can compare the effects of market volatilities on Bio Gene and Imugene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Gene with a short position of Imugene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Gene and Imugene.

Diversification Opportunities for Bio Gene and Imugene

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Bio and Imugene is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Bio Gene Technology and Imugene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Imugene and Bio Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Gene Technology are associated (or correlated) with Imugene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Imugene has no effect on the direction of Bio Gene i.e., Bio Gene and Imugene go up and down completely randomly.

Pair Corralation between Bio Gene and Imugene

Assuming the 90 days trading horizon Bio Gene Technology is expected to generate 1.14 times more return on investment than Imugene. However, Bio Gene is 1.14 times more volatile than Imugene. It trades about 0.01 of its potential returns per unit of risk. Imugene is currently generating about -0.22 per unit of risk. If you would invest  4.50  in Bio Gene Technology on September 2, 2024 and sell it today you would lose (0.10) from holding Bio Gene Technology or give up 2.22% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Bio Gene Technology  vs.  Imugene

 Performance 
       Timeline  
Bio Gene Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Bio Gene is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Imugene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Imugene has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Bio Gene and Imugene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bio Gene and Imugene

The main advantage of trading using opposite Bio Gene and Imugene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Gene position performs unexpectedly, Imugene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imugene will offset losses from the drop in Imugene's long position.
The idea behind Bio Gene Technology and Imugene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stocks Directory
Find actively traded stocks across global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories